Literature DB >> 19000272

Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses.

L C Douglas1, N Y Yi, J L Davis, J H Salmon, B C Gilger.   

Abstract

In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 degrees C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000272     DOI: 10.1111/j.1365-2885.2008.00986.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  8 in total

1.  Deep subconjunctival injection of gentamicin for the treatment of bacterial conjunctivitis in macaques (Macaca mulatta and Macaca fascicularis).

Authors:  Sylvia I Gografe; Barbara C Hansen; Kenneth D Hansen
Journal:  Lab Anim (NY)       Date:  2015-03       Impact factor: 12.625

2.  Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.

Authors:  Mónica Anayántzin Linares-Alba; Magda Berenice Gómez-Guajardo; Joice Furtado Fonzar; Dennis E Brooks; Gustavo Adolfo García-Sánchez; Maria Josefa Bernad-Bernad
Journal:  J Ocul Pharmacol Ther       Date:  2015-10-15       Impact factor: 2.671

3.  Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.

Authors:  Wai T Wong; Samuel Dresner; Farzin Forooghian; Tanya Glaser; Lauren Doss; Mei Zhou; Denise Cunningham; Katherine Shimel; Molly Harrington; Keri Hammel; Catherine A Cukras; Frederick L Ferris; Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-26       Impact factor: 4.799

4.  Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.

Authors:  Alejandra Nieto; Huiyuan Hou; Sang Woong Moon; Michael J Sailor; William R Freeman; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-22       Impact factor: 4.799

Review 5.  A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.

Authors:  Nasiq Hasan; Rohan Chawla; Nawazish Shaikh; Sindhuja Kandasamy; Shorya Vardhan Azad; M Dheepak Sundar
Journal:  Ther Adv Ophthalmol       Date:  2022-05-18

6.  Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.

Authors:  Mayara Rodrigues Brandão De Paiva; Nayara Almeida Lage; Maria Carolina Andrade Guerra; Marcos Paulo Gomes Mol; Marcela Coelho Silva Ribeiro; Gustavo De Oliveira Fulgêncio; Dawidson A Gomes; Isabela Da Costa César; Sílvia Ligório Fialho; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2018-11-19       Impact factor: 2.379

7.  A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis.

Authors:  Brandon N Phillips; Keith J Wroblewski
Journal:  J Ophthalmic Inflamm Infect       Date:  2010-12-07

8.  Therapeutic Effect of Rapamycin-Loaded Small Extracellular Vesicles Derived from Mesenchymal Stem Cells on Experimental Autoimmune Uveitis.

Authors:  Huan Li; Zhihui Zhang; Yongtao Li; Lin Su; Yanan Duan; Hui Zhang; Jinying An; Tianwen Ni; Xiaorong Li; Xiaomin Zhang
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.